Late results were determined for 42 patients who had undergone detorsion and fixation for unilateral testicular torsion in the prepubertal and pubertal age. Exocrine and endocrine function for the testes was determined in 30 patients who had reached postpuberal age. Patients who underwent detorsion and fixation 8 hours or less after the onset of symptoms had normal-sized testicles and only slight changes in testicular morphology. When treatment was delayed and detorsion was done more than 8 hours later a marked decrease was observed in testicular size. The exocrine function in patients with torsion was reduced. The semen quality, as judged by 2 semen analyses, was normal in 15 patients, doubtful in 3 and pathological in 12. Even when detorsion was done 4 hours or less after the onset of symptoms the exocrine function of the testes was normal in only 50 per cent of the cases. In patients with doubtful and pathological sperm analyses higher follicle-stimulating and luteinizing hormone levels were observed.
Gene therapy approaches for malignant brain tumors evolved from the need to develop new treatment modalities, increasing insights in the molecular basis of tumorigenesis and the advent of recombinant DNA technology. Immunotherapy of tumors growing in an immunologically privileged organ is a challeng ing task for researchers and clinicians. Both strategies, systemic immunization and local overexpression of cytokines in the brain tumor, have been successfully applied to experimental tumor models. The first clinical gene immunotherapy trials of malignant gliomas uses a vaccine consisting of tumor cells and fibro-blasts genetically modified to express interleukin-2. Chemotherapy of brain tumors is based on the conversion of relatively nontoxic prodrugs into cytotoxic chemotherapeutic agents by suicide genes. Cytosine deaminase from E. coli and thymidine kinase from herpes simplex virus confer lethal cytotoxicity to cells expressing either one of the suicide genes in the presence of the appropriate prodrug 5-fluorocytosine or ganciclovir. Several gene therapy trials have been approved for the treatment of malignant brain tumors with herpes simplex thymidine kinase and ganciclovir. Insights in the molecular basis of tumorigenesis stimulated therapy approaches for restoration of cell cycle gene functions and growth control in malignant tumor cells. Introduction of wild-type p53 tumor suppressor gene into tumor cells lacking the normal protein has not only been shown to revert the malignant phenotype, but also to induce apoptosis in response to DNA damaging by conventional chemotherapy and radiotherapy treatment. These findings are now being translated into clinical gene transfer trials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.